# Nipah virus
Latest news and articles about Nipah virus
Total: 2 articles found
China’s COVID Pill VV116 Shows Promise Against Deadly Nipah Virus — But Clinical and Commercial Hurdles Remain
A Wuhan Institute-led study finds that VV116, an oral antiviral developed in China for COVID-19, inhibits Nipah virus in cell cultures and improves survival in a rodent model. The result offers a potential stopgap against a pathogen with high fatality and no approved treatments, but clinical trials and regulatory approval are still required before human use. Corporate partners gave mixed responses and markets briefly rallied on the news.
Market Ripples and Social Controls: China’s Gold Surge, Tencent’s Big Red Packet and a Gansu Quake Shake the Week
A 5.5-magnitude quake rattled Gansu but caused no confirmed casualties as emergency teams responded. China tightened internet protections for minors, markets saw a gold-led rally while mainland turnover topped 3 trillion yuan, Tencent plans a 1 billion yuan red-packet campaign for its new app, and KFC raised delivery prices slightly amid cost pressure.